LoValTech

LoValTech is a biotechnology company focused on developing innovative nasal vaccines aimed at combating infectious diseases, including Covid-19. The company specializes in creating protein vaccines for nasal administration, which are designed to elicit a strong protective immune response and facilitate early neutralization of the virus and its variants. By targeting the mucosal immune system, LoValTech's vaccines aim to significantly reduce the risk of contagion and prevent vaccinated individuals from spreading infections. This approach represents a potential advancement in vaccination strategies, providing effective protection against a range of infectious diseases.